← Leaderboards
Trudy G. Morrison
Univ Of Massachusetts Med Sch Worcester
$6,555,962
Attributed
$6,555,962
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $738.8K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,555,962 · 5
By mechanism
R01$5,196,039 · 2
R56$1,045,257 · 2
R21$314,666 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Dale L Greiner$17,425,144
- Jennifer P Wang$8,271,520
- John P Mordes$1,313,577
- Madelyn Ruth Schmidt$539,000
- Susan L Swain$26,012,075
Others in their field
Top investigators on “Newcastle Disease Virus”
- Thomas M Moran · Mount Sinai School Of Medicine Of Cuny$8,240,161
- Peter Palese · Mount Sinai School Of Medicine Of Nyu$7,208,855
- Christopher F Basler · Washington University$5,818,393
- Thomas William Geisbert · Boston University Medical Campus$5,617,731
- Christopher Broder · Henry M. Jackson Fdn For The Adv Mil/Med$5,515,762
- Joan E. Durbin · Research Inst Nationwide Children'S Hosp$4,321,167
Research focus
Newcastle Disease VirusAntibodiesGlycoproteinsRespiratory Syncytial Virus VaccinesVaccinesImmunizationProteinsPlasma CellsRespiratory Syncytial Virus Rsv F ProteinsMemoryNovel VirusVaccine CandidateVirus-Like ParticleResponseAdjuvantElderlyNeutralizing AntibodyPathogenImmune ResponseRespiratory Syncytial VirusCotton RatsAffinityNovel VaccinesFailure
Grant awards (13)
Development of an RSV vaccine for the elderly$721,972
R01 · FY2024 · AI · contact PI
Development of an RSV vaccine for the elderly$721,972
R01 · FY2023 · AI · contact PI
Development of an RSV vaccine for the elderly$721,972
R01 · FY2022 · AI · contact PI
Development of an RSV vaccine for the elderly$721,972
R01 · FY2021 · AI · contact PI
Development of an RSV vaccine for the elderly$738,847
R01 · FY2020 · AI · contact PI
Role of F Protein Conformation in RSV Vaccine Efficacy$634,007
R56 · FY2016 · AI · contact PI
Humoral Immune Responses to Virus-like Particle Vaccine Candidates for RSV$411,250
R56 · FY2011 · AI · contact PI
Paramyxovirus Membrane Fusion$357,750
R01 · FY2005 · AI
Paramyxovirus Membrane Fusion$357,750
R01 · FY2004 · AI
Paramyxovirus Membrane Fusion$357,750
R01 · FY2003 · AI
Paramyxovirus Membrane Fusion$198,126
R01 · FY2002 · AI
Paramyxovirus Entry$314,666
R21 · FY2001 · AI
PARAMYXOVIRUS MEMBRANE FUSION$297,928
R01 · FY2000 · AI